208 related articles for article (PubMed ID: 10567899)
1. c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients.
Lê MG; Mathieu MC; Douc-Rasy S; Le Bihan ML; Adb El All H; Spielmann M; Riou G
Int J Cancer; 1999 Dec; 84(6):562-7. PubMed ID: 10567899
[TBL] [Abstract][Full Text] [Related]
2. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer.
Neri A; Marrelli D; Roviello F; DeMarco G; Mariani F; DeStefano A; Megha T; Caruso S; Corso G; Cioppa T; Pinto E
Breast Cancer Res Treat; 2006 Sep; 99(1):77-83. PubMed ID: 16541314
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A
Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951
[TBL] [Abstract][Full Text] [Related]
5. Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer.
Jansen RL; Joosten-Achjanie SR; Volovics A; Arends JW; Hupperets PS; Hillen HF; Schouten HC
Anticancer Res; 1998; 18(6A):4455-62. PubMed ID: 9891509
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between apoptotic index, bcl-2 protein expression and progression and prognosis in breast carcinoma].
Zhang GJ; Kimijima I; Watanabe T; Kanno M; Sagara H; Furukawa Y; Tsuchiya A; Abe R
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():415-21. PubMed ID: 9589045
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: a pathway to metastatic progression in human breast cancer.
Sierra A; Castellsagué X; Escobedo A; Lloveras B; García-Ramirez M; Moreno A; Fabra A
Int J Cancer; 2000 Mar; 89(2):142-7. PubMed ID: 10754491
[TBL] [Abstract][Full Text] [Related]
9. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes.
Arun B; Kilic G; Yen C; Foster B; Yardley D; Gaynor R; Ashfaq R
Cancer; 2003 Dec; 98(12):2554-9. PubMed ID: 14669273
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
Hofmockel G; Wittmann A; Dammrich J; Bassukas ID
Anticancer Res; 1996; 16(6B):3807-11. PubMed ID: 9042262
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
Pich A; Margaria E; Chiusa L
J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Chikhlikar PR; Ghosh N; Trivedi TI
Ann Surg Oncol; 2000 May; 7(4):305-11. PubMed ID: 10819372
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma.
Bánkfalvi A; Tory K; Kemper M; Breukelmann D; Cubick C; Poremba C; Füzesi L; Lellè RJ; Böcker W
Pathol Res Pract; 2000; 196(7):489-501. PubMed ID: 10926327
[TBL] [Abstract][Full Text] [Related]
15. Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy.
Gallo O; Chiarelli I; Boddi V; Bocciolini C; Bruschini L; Porfirio B
Int J Cancer; 1999 Dec; 84(6):573-9. PubMed ID: 10567901
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma.
Lee WY; Jin YT; Tzeng CC
Anticancer Res; 1996; 16(5A):3007-12. PubMed ID: 8917421
[TBL] [Abstract][Full Text] [Related]
18. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.
Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases.
Olopade OI; Adeyanju MO; Safa AR; Hagos F; Mick R; Thompson CB; Recant WM
Cancer J Sci Am; 1997; 3(4):230-7. PubMed ID: 9263629
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma.
Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB
Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
